| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
|
| ln Vitro |
BJE6-106 (B106) (0.2 μM, 0.5 μM; 24-72 hours) reduces cell survival in melanoma cell lines carrying NRAS mutations [1]. BJE6-106 (B106) (0.2 μM, 0.5 μM; 6-24 hours) causes caspase-dependent apoptosis and enhances caspase 3/7 activity. The effect of B106 is stronger than that of Rottlerin (10-fold) in SBcl2 cells [1]. BJE6-106 (B106) (0.5 μM; 2-10 hours) triggers the MKK4-JNK-H2AX pathway by triggering MKK4, JNK and H2AX activation at separate periods in SBcl2 cells [1].
|
|---|---|
| Cell Assay |
Cell Viability Assay[1]
Cell Types: Melanoma cell lines with NRAS mutations: SBcl2, FM6, SKMEL2, WM1366, WM1361A, and WM852 Cell Tested Concentrations: 0.2 μM, 0.5 μM Incubation Duration: 24 hrs (hours), 48 hrs (hours), or 72 hrs (hours) Experimental Results: Inhibition of cell survival in melanoma cell lines. Apoptosis analysis[1] Cell Types: SBcl2 Cell Tested Concentrations: 0.2 μM, 0.5 μM Incubation Duration: 6 hrs (hours), 12 hrs (hours) or 24 hrs (hours) Experimental Results: Induction of caspase 3/7 activation. Western Blot Analysis[1] Cell Types: SBcl2 Cell Tested Concentrations: 0.2 μM, 0.5 μM Incubation Duration: 2 hrs (hours), 5 hrs (hours), 10 hrs (hours) Experimental Results: Increased phosphorylation of MKK4, JNK and H2AX. |
| References |
| Molecular Formula |
C26H23NO2
|
|---|---|
| Molecular Weight |
381.4663
|
| Exact Mass |
381.172
|
| CAS # |
1564249-38-2
|
| PubChem CID |
85471521
|
| Appearance |
White to off-white solid powder
|
| LogP |
5.6
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
29
|
| Complexity |
606
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O1C2C(C([H])=O)=C([H])C(=C([H])C=2C([H])=C([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])N1C2=C([H])C([H])=C([H])C([H])=C2C2=C([H])C([H])=C([H])C([H])=C12
|
| InChi Key |
QLDDENZBVHBRKN-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C26H23NO2/c1-26(2)13-11-19-15-18(16-20(17-28)25(19)29-26)12-14-27-23-9-5-3-7-21(23)22-8-4-6-10-24(22)27/h3-11,13,15-17H,12,14H2,1-2H3
|
| Chemical Name |
6-(2-carbazol-9-ylethyl)-2,2-dimethylchromene-8-carbaldehyde
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~50 mg/mL (~131.07 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (6.55 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.55 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.6214 mL | 13.1072 mL | 26.2144 mL | |
| 5 mM | 0.5243 mL | 2.6214 mL | 5.2429 mL | |
| 10 mM | 0.2621 mL | 1.3107 mL | 2.6214 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
